Mediwhale, the AI-empowered health diagnostics company that uses retina scans to diagnose future cardiac and kidney disorder risk quickly and easily, announced today it has been accepted into the 2023 cohort of StartX, an exclusive accelerator program affiliated with Stanford University and Stanford Healthcare.
A paper presented by Eric Loucks at the American Heart Association Scientific Session shows that after 6 months of participating in a personalized mindfulness program that taught participants to use.
/PRNewswire/ NovoMedix, LLC ("NovoMedix"), a biotechnology company developing novel, multi-pathway modulators for fibrosis and cancer, today announced the.